Van Hulzen Asset Management’s CareDx CDNA Stock Holding History

Van Hulzen Asset Management’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-30	Closed	-$643	–	426
2024 Q4	$643	Buy	+30	New	+$730	﹤0.01%	1073

Other funds holding CDNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Van Hulzen Asset Management's CDNA Position: Q1 2025 in Review

Van Hulzen Asset Management sold out of CareDx (CDNA) in Q1 2025, closing a stake of 30 shares — an estimated $643 sold.

Van Hulzen Asset Management first reported a position in CDNA in Q4 2024 and held it in 1 quarter. The position peaked at $643 in Q4 2024. 218 funds tracked by Wall St. Rank hold CDNA as of Q1 2025.

Van Hulzen Asset Management reported no remaining CareDx position as of Q1 2025 after selling out during the quarter.
Van Hulzen Asset Management sold 30 CareDx shares in Q1 2025, an estimated $643.
Van Hulzen Asset Management first reported a position in CareDx in Q4 2024 and held it in 1 quarter.
Van Hulzen Asset Management's CareDx position peaked at $643 in Q4 2024.
218 funds tracked by Wall St. Rank held CareDx as of Q1 2025.

Based on Van Hulzen Asset Management's 13F filing for Q1 2025, filed 14 May 2025.